Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
GRO Biosciences
AddedFeb 15, 2024
UpdatedJun 18, 2026
GRO Biosciences

GRO Biosciences

Series A

GRO Biosciences innovates protein therapeutics using novel amino acids to combat incurable diseases.

HQ
Boston, MA, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

GRO Biosciences, founded with the mission to revolutionize protein therapeutics, focuses on utilizing novel amino acids to develop treatments for previously incurable diseases. The company offers innovative solutions through its proprietary GRO Platform and ProGly™ programs, which enhance the therapeutic potential of proteins. GRO Biosciences aims to address significant unmet medical needs by leveraging advanced bioengineering techniques to create more effective and durable protein-based therapies.

Notable figures affiliated with GRO Biosciences include leading scientists and industry experts who contribute to its groundbreaking research and development efforts. The company has attracted investment from prominent biotech venture capital firms, underscoring its potential and credibility in the market. Key achievements include successful preclinical studies demonstrating the efficacy of their novel therapeutics. GRO Biosciences is poised to make a substantial impact on the field of protein therapeutics, offering hope for patients with diseases that currently lack effective treatments.

GRO Biosciences - Similar Companies

Grove Biopharma logo

Grove Biopharma

grovebiopharma.com

Groove Biopharma logo

Groove Biopharma

AI Proteins logo

AI Proteins

aiproteinstx.com

ProFound Therapeutics logo

ProFound Therapeutics

profoundtx.com

Gamma Biosciences logo

Gamma Biosciences

Generate Biomedicines logo

Generate Biomedicines

Orange Grove Bio logo

Orange Grove Bio

orangegrovebio.com

Petri Bio logo

Petri Bio

petribio.com

InterVenn Biosciences logo

InterVenn Biosciences

intervenn.com

Glyphic Biotechnologies logo

Glyphic Biotechnologies

glyphic.bio

Entrinsic Bioscience logo

Entrinsic Bioscience

Juvena Therapeutics logo

Juvena Therapeutics

Glycos Biotechnologies logo

Glycos Biotechnologies

glycosbio.com

GEn1E Lifesciences logo

GEn1E Lifesciences

gen1e.com

Protillion Biosciences logo

Protillion Biosciences

protillion.com

GRO Biosciences - Quick Facts

Who are GRO Biosciences' competitors?

Companies similar to GRO Biosciences include Grove Biopharma, Groove Biopharma, AI Proteins and ProFound Therapeutics.

When was GRO Biosciences founded?

GRO Biosciences was founded in 2016.

Where is GRO Biosciences' headquarters located?

GRO Biosciences' headquarters is located in Boston, MA, US.

When was GRO Biosciences' last funding round?

GRO Biosciences' most recent funding round was for $25M (USD) in November 2021.

How much has GRO Biosciences raised to-date?

As of Nov 1, 2021, GRO Biosciences has raised a total of $32.3M (USD).

How many employees does GRO Biosciences have?

GRO Biosciences has 44 employees as of Feb 5, 2024.

GRO Biosciences - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Protein Therapeutics
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified